Very salient point eyes.
IMO, when Mesoblast has Remestemcel-L approved by the most powerful body in the world, the FDA, for use on patients with the final fatal stage of COVID-19, ARDS, the noise around the share price will die off as the market cap moves from AU$1B to multiple AU$10B's and Mesoblast will be confronted with some tough decisions regarding supply of it's Stem Cells as other jurisdictions seek out Mesoblast and apply for our MSC's.
IMO, it is a foregone conclusion that Mesoblast have been engaged very closely with Lonza since the outbreak and have developed multiple mass manufacturing plans ready to "push the button".
GLTAH
Very salient point eyes.IMO, when Mesoblast has Remestemcel-L...
-
- There are more pages in this discussion • 16,915 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.51 |
Change
0.020(1.34%) |
Mkt cap ! $1.689B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $11.92M | 7.980M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 31871 | $1.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.51 | 61772 | 11 |
View Market Depth
| Last trade - 12.58pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |